Nanogen Company Description
Nanogen digs into DNA to diagnose disease. The company makes diagnostic reagents and test kits that detect a variety of infectious diseases -- including several herpes viruses and influenza -- as well as some cancers and genetic conditions. Its Q-PCR Alert and MGB Alert tests employ real-time PCR technology (a method of DNA amplification commonly used in molecular testing) and its proprietary MGB technology. Nanogen also makes point-of-care tests, including a couple of tests administered in the emergency room to diagnose heart attack and congestive heart failure. The firm in 2008 agreed to combine its operations with French diagnostics company Elitech in a reverse merger.
View the Comprehensive Company Description for Nanogen
The Company Description provides a historical perspective of Nanogen's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Nanogen's evolution in the marketplace.
